Ignite Creation Date:
2024-05-05 @ 6:37 PM
Last Modification Date:
2024-10-26 @ 9:35 AM
Study NCT ID:
NCT00511732
Status:
COMPLETED
Last Update Posted:
2012-04-30
First Post:
2007-08-03
Brief Title:
18-Week Randomized Double-blind Placebo Controlled Forced Titration Study of Patients With Type 2 Diabetes
Sponsor:
Mannkind Corporation
Organization:
Mannkind Corporation
Study Overview
Official Title:
A Randomized Double-blind Controlled Stepwise Titration Study to Evaluate Dose Response to Prandial Administration of Inhaled TechnosphereInsulin or Technosphere in Patients With Type 2 Diabetes Mellitus Who Are Sub-optimally Treated
Status:
COMPLETED
Status Verified Date:
2012-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Designed to evaluate dose response of force-titrated prandial administration of TI as compared to placebo TP in subjects with Type 2 diabetes who were suboptimally controlled
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None